Simplex Trading’s LENZ Therapeutics LENZ Stock Holding History

Simplex Trading’s Portfolio LENZ Stock Details LENZ Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$10.2K	Sell	1,800 -5,600	-76%	-$45.1K	﹤0.01%	7679
2026 Q1	$67.7K	Sell	7,400 -69,400	-90%	-$975K	﹤0.01%	5528
2025 Q4	$1.23M	Buy	76,800 +74,400	+3,100%	+$2.17M	﹤0.01%	2427
2025 Q3	$111K	Buy	2,400 +500	+26%	+$18.4K	﹤0.01%	5628
2025 Q2	$55K	Buy	+1,900	New	+$51.7K	﹤0.01%	5841
2023 Q3	–	Sell	-42,329	Closed	-$770K	–	10035
2023 Q2	$770K	Sell	42,329 -328	-0.8%	-$6.55K	﹤0.01%	2855
2023 Q1	$731K	Buy	42,657 +33,571	+369%	+$543K	﹤0.01%	2888
2022 Q4	$211K	Buy	9,086 +215	+2%	+$4.98K	﹤0.01%	4161
2022 Q3	$196K	Buy	+8,871	New	+$211K	﹤0.01%	4638

Other funds holding LENZ

RCM

RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return

AWG

Alpha Wave Global New York $6.24B AUM 59.73% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

VVM

Versant Venture Management San Francisco, California $163M AUM 240.43% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Squarepoint New York $90.5B AUM 33.95% 1-Year Est. Return

Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

7IH

72 Investment Holdings Stamford, Connecticut $50M AUM 647.58% 1-Year Est. Return

Simplex Trading's LENZ Position: Q2 2026 in Review

Simplex Trading reduced its LENZ Therapeutics (LENZ) stake by 60% in Q2 2026, selling an estimated $33.5K and leaving 2,772 shares worth $15.7K. The position accounts for ﹤0.01% of the portfolio, ranked #7315.

Simplex Trading first reported a position in LENZ in Q2 2022 and has held it in 8 quarters since. The position peaked at $189K in Q2 2022. 145 funds tracked by Wall St. Rank hold LENZ as of Q2 2026.

Simplex Trading held 2,772 shares of LENZ Therapeutics worth $15.7K as of Q2 2026.
Simplex Trading sold 4,155 LENZ Therapeutics shares in Q2 2026, an estimated $33.5K.
LENZ Therapeutics made up ﹤0.01% of Simplex Trading's portfolio in Q2 2026, its #7315 holding.
Simplex Trading first reported a position in LENZ Therapeutics in Q2 2022 and has held it in 8 quarters since.
Simplex Trading's LENZ Therapeutics position peaked at $189K in Q2 2022.
145 funds tracked by Wall St. Rank held LENZ Therapeutics as of Q2 2026.

Based on Simplex Trading's 13F filing for Q2 2026, filed 12 Aug 2026.